Managing Healthcare Workers Exposed to COVID-19
Primary care practices should develop a policy to guide practice procedures if a healthcare worker
(HCW) has been exposed to COVID-19. This document provides guidance on how to develop those
policies in accordance with current CDC guidelines.
In summary:
1. Follow CDC guidelines
2. Customize guidelines to your practice
3. Communicate policy to staff and providers
4. Adjust actions relative to vulnerability of individual staff members
5. Update your policy as new information is available
Managing HCW Exposure
There has been a high degree of interest and concern on the management of HCWs who have been
exposed to COVID-19 positive patients or who have tested positive for COVID-19. The guidance for these
exposures has evolved over the past several months as more is known about the transmissibility of the
virus, and your practice should follow and remain up to date on the most recent CDC guidance. The
following link provides the current in depth CDC guidance: https://www.cdc.gov/coronavirus/2019-
ncov/hcp/guidance-risk-assesment-hcp.html
The guidance highlights the importance of understanding the level of transmission in your community,
the type of exposure and the vulnerability of the person exposed. The overall goals of the guidance are
the reduction of risk of further viral transmission, the safety of the exposed HCW, and the simultaneous
need to provide uninterrupted healthcare services to the public. Please review this guidance and use it
to create a practice specific protocol for managing exposure. The protocol should be made available to
all practice staff and amended as needed. Understanding that this is an evolving situation, a provider or
designated staff member should take the lead for updating and communicating any changes in the
guidance. The MDPCP PMO will alert practices as we are aware of changing guidance. CDC also provides
guidelines for managing staff shortages should a shortage occur.
Returning to work after exposure
After a staff member has been exposed to COVID-19 there is further guidance as to the timing to return
to work, for both symptomatic and asymptomatic HCWs. Again, the guidance is detailed and takes into
consideration the vulnerability of the HCW and the nature of the work they perform. This guidance
should be included in the communications to staff and updated as new guidance is available. For
clearance to return to work, there is a symptom-based criteria and testing criteria. In alignment with
CDC and due to test result timing, we strongly suggest using the symptom-based strategy. Finally, when
HCWs return to work they should take continued source control precautions.
https://www.cdc.gov/coronavirus/2019-ncov/hcp/return-to-work.html
Policy Template (adapted from CDC guidance)
Be sure to adapt and update this policy to your context. Every case is different and your practice should
adapt to your specific scenario.
Proper precautions and monitoring of health care workers
To prevent the spread of COVID-19, health care workers should follow all recommended
infection prevention and source control practices, including wearing a facemask at all times
while in the healthcare facility.
Healthcare workers should self-monitor for symptoms of respiratory illness before coming into
work every day. If you develop symptoms at work, inform your supervisor and go home
immediately. Isolate at home when you are ill and showing symptoms.
Health Care Workers Exposed to Patients with Confirmed COVID-19
If you are asymptomatic but have been exposed to a patient with confirmed COVID-19, use the
guidance in the table below to determine if you should continue to come into work (source:
CDC)
Exposure
PPE Used
Work Restrictions
Prolonged and close
contact with a
patient, visitor, or
HCW with confirmed
COVID-19
HCW not wearing a
respirator or facemask
HCW not wearing eye
protection if the person
with COVID-19 was not
wearing a cloth face
covering or facemask
HCW not wearing all
recommended PPE (i.e.,
gown, gloves, eye
protection, respirator) while
performing an aerosol-
generating procedure
Exclude from work for 14 days after last
exposure
Advise HCW to monitor themselves for fever or
symptoms consistent with COVID-19
Any HCW who develops fever or symptoms
consistent with COVID-19 should immediately
contact their established point of contact (e.g.,
occupational health program) to arrange for
medical evaluation and testing.
HCW other than those
with exposure risk
described above
N/A
No work restrictions
Follow all recommended infection prevention
and control practices, including wearing a
facemask for source control while at work,
monitoring themselves for fever or symptoms
consistent with COVID-19 and not reporting to
work when ill, and undergoing active screening
for fever or symptoms consistent with COVID-
19 at the beginning of their shift.
Any HCW who develops fever or symptoms
consistent with COVID-19 should immediately
self-isolate and contact their established point
of contact (e.g., occupational health program)
to arrange for medical evaluation and testing.
Health Care Workers Who are Ill
If you have suspected or confirmed COVID-19, do not come into work. Inform your supervisor
and immediately self-isolate, and find a local testing site to get tested for COVID-19. Inform your
supervisor when you receive test results.
If necessary, contact tracing will occur through local health department activities and not
directly from the practice.
Return to Work After Exposure
If you previously had suspected or confirmed COVID-19, follow the following guidelines to
determine when you can return to work (source: CDC)
Symptomatic HCW with suspected or confirmed COVID-19:
Symptom-based strategy. Exclude from work until:
At least 3 days (72 hours) have passed since recovery defined as resolution of
fever without the use of fever-reducing medications and improvement in
respiratory symptoms (e.g., cough, shortness of breath); and,
At least 10 days have passed since symptoms first appeared OR
Test-based strategy. Exclude from work until:
Resolution of fever without the use of fever-reducing medications and
Improvement in respiratory symptoms (e.g., cough, shortness of breath), and
Negative results of an FDA Emergency Use Authorized COVID-19 molecular
assay for detection of SARS-CoV-2 RNA from at least two consecutive
respiratory specimens collected ≥24 hours apart (total of two negative
specimens). See Interim Guidelines for Collecting, Handling, and Testing Clinical
Specimens for 2019 Novel Coronavirus (2019-nCoV). Of note, there have been
reports of prolonged detection of RNA without direct correlation to viral culture.
HCW with laboratory-confirmed COVID-19 who have not had any symptoms:
Time-based strategy. Exclude from work until:
10 days have passed since the date of their first positive COVID-19 diagnostic
test assuming they have not subsequently developed symptoms since their
positive test. If they develop symptoms, then the symptom-based or test-based
strategy should be used. Note, because symptoms cannot be used to gauge
where these individuals are in the course of their illness, it is possible that the
duration of viral shedding could be longer or shorter than 10 days after their
first positive test. OR
Test-based strategy. Exclude from work until:
Negative results of an FDA Emergency Use Authorized COVID-19 molecular
assay for detection of SARS-CoV-2 RNA from at least two consecutive
respiratory specimens collected ≥24 hours apart (total of two negative
specimens). Note, because of the absence of symptoms, it is not possible to
gauge where these individuals are in the course of their illness. There have
been reports of prolonged detection of RNA without direct correlation to viral
culture.